Table of contents
TraceLink joins industry innovators in the LogiPharma AI & Technology Report 2025 to explore how artificial intelligence and agentic orchestration are transforming the future of life sciences.
Artificial intelligence is no longer a theoretical promise — it’s reshaping how pharmaceutical and healthcare supply chains operate. The LogiPharma AI & Technology Report 2025 brings together perspectives from the world’s leading life sciences organizations, revealing where AI is driving measurable business value, where challenges remain, and how technology is enabling smarter, faster, and more resilient supply chain orchestration.
TraceLink is proud to contribute to this year’s report, sharing insights on how intelligent, agentic orchestration is helping life sciences companies turn fragmented data into connected intelligence — accelerating decision-making, improving compliance, and ensuring life-saving treatments reach patients without delay.
Key Insights:
- AI in Action: How top pharmaceutical companies are embedding AI into daily decision-making to improve resilience, speed, and accuracy.
- Breaking Barriers: What leaders identify as the biggest roadblocks to scaling AI — and the strategies helping them succeed.
- Agentic Orchestration: TraceLink’s vision for intelligent digital agents that monitor, detect, and resolve issues across the end-to-end supply chain in real time.
AI is rapidly evolving from an experimental tool to a strategic co-pilot. The opportunity ahead is using AI agents to accelerate decisions that directly lower inventory, improve margins, and unlock growth.
Shabbir Dahod, President & CEO, TraceLink
Discover collective insights from across the life sciences industry — from AI adoption trends to success factors for digital transformation. Complete the form to access your complimentary copy and explore how agentic orchestration is redefining supply chain performance.
